Sign up to save your podcasts
Or
Share Cardiometabolic Considerations: The Role of LDL-C in ASCVD Risk Assessment & Insights into Optimal Management
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Cardiometabolic Considerations: The Role of LDL-C in ASCVD Risk Assessment & Insights into Optimal Management
Guest: Norman Lepor, MD, FACC, FAHA, FSCAI
Tune in to hear Dr. Norman Lepor from the UCLA Geffen School of Medicine discuss the role of LDL-C and comorbidities in atherosclerotic cardiovascular disease (ASCVD) risk assessment as well as the limitations of statin treatment.
10/21 121913
View all episodes
By ReachMD
4
11 ratings
Guest: Norman Lepor, MD, FACC, FAHA, FSCAI
Tune in to hear Dr. Norman Lepor from the UCLA Geffen School of Medicine discuss the role of LDL-C and comorbidities in atherosclerotic cardiovascular disease (ASCVD) risk assessment as well as the limitations of statin treatment.
10/21 121913
More shows like Medical Industry Feature
View all
SexMed
3 Listeners
Partners in Practice
3 Listeners
Second Opinion LIVE!
0 Listeners
Medical Breakthroughs from Penn Medicine
6 Listeners
Advances in Women's Health
15 Listeners
GI Insights
18 Listeners
Conference Coverage
0 Listeners